Skip to main content
Polaris AI Pharma Corp. logo

Polaris AI Pharma Corp. — Investor Relations & Filings

Ticker · 041910 ISIN · KR7041910001 KO Manufacturing
Open in API
Filings indexed 164 across all filing types
Latest filing 2025-12-24 Board/Management Inform…
Country KR South Korea
Listing KO 041910

About Polaris AI Pharma Corp.

https://polarisaipharma.com/

Polaris AI Pharma Corp., formerly known as ESTECHPHARMA CO., LTD, is a company engaged in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) and fine chemicals. The company specializes in producing raw materials for generic drugs across various therapeutic categories. Its product portfolio includes APIs for treatments such as anti-thrombosis, anti-ulcer, asthma, and alcohol dependence.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding the change of the CEO (Representative Director) of Polaris AI Pharma. It details the resignation of the former CEO and the appointment of a new one, including the effective date, board resolution date, and the professional background of the new appointee. This falls directly under the category of board/management changes.
2025-12-24 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details specific changes to the company's board of directors, including the appointment of a new outside director and the resignation of an existing one. This falls directly under the category of Board/Management Information (MANG).
2025-12-24 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for the upcoming Annual General Meeting (AGM). It specifies the record date (2025-12-31) and the purpose (determining shareholders for the 27th AGM). Since it is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2025-12-16 Korean
주주총회소집결의
AGM Information Classification · 95% confidence The document is a notice of convening a shareholders' meeting (주주총회소집결의) scheduled for December 24, 2025. It includes details about the meeting time, place, agenda items (mainly the election of directors), and board resolution date. The document is short (1194 characters) and focuses on announcing the meeting and its agenda rather than providing detailed financial data or results. This fits the category of an announcement related to the convening of a shareholders' meeting rather than the meeting materials or voting results themselves. Therefore, the appropriate classification is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings, including notices of meeting and agenda.
2025-10-27 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the setting of a record date (기준일) and the closure period for the shareholder register (주주명부폐쇄기간) for the purpose of determining shareholders entitled to vote at a special shareholders meeting. It includes specific dates and references to company articles and relevant laws. The document is brief (459 characters) and does not contain financial data or detailed reports. It is an official announcement related to shareholder records and meeting preparations, which fits the category of Regulatory Filings (RNS) as it does not match other more specific categories like AGM Information or Notice of Dividend. Therefore, the classification is Regulatory Filings (RNS).
2025-10-27 Korean
[기재정정]분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '(주)폴라리스에이아이파마' (Polaris AI Pharma Corp.). It contains detailed financial statements, management discussion and analysis, and corporate governance information for the first quarter of 2025. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.